Polymorphism of the Atg16L1 is connected with CD, and the intestinal mucosa without Atg16L1 shows Paneth cell deficiency and TNF-mediated cell necrosis, whereas TNF-α or receptor-interacting protein kinase inhibitors reduce inflammation in IBD models [142]. This evidence concerns the gene TNF and inflammatory bowel disease.